Published October 6, 2020 | Version 1.2
Project milestone Open

A Biocidal Active Anionic H2O8 Oxygen Solution with Bronchodilative & Oxygenizing Features for the Treatment of Coronaviral Infection Related Hypoxia

Description

DESCRIPTION OF THE INVENTION

 

The invention relates to a composition with Antiviral, Antiseptic, Antibacterial, Antihistamic, Antipruritic and Anti-inflammatory effects created for the treatment of viral infections infecting humans and living things, bacteria, fungi.

 

The invention relates to a composition with a biocidal effect for the removal of all types of viruses, bacteria, fungi and molds suspended in the air, settled in skin, hair, skin, items and objects, settled in water and soil.

 

In particular, the invention relates to the use of HOCL (Hypochlorous acid) and H 2 O 8 (octaoxidant) in the treatment of viral infections and in the prevention of outbreaks.

 

Known State of the Technique

Today, antiviral, antiseptic, antibacterial, antihistamic, antipruritic and anti-inflammatory, biocidal agents are agents used against infections caused by viruses, bacteria, fungi and molds. They are used to control or eliminate infections and to kill viruses, bacteria, fungi and molds. Corona Covid 19 and similar viruses and bacteria that damage human and living creatures by being infected have a cationic structure. Currently, it is a drug with antiviral, antiseptic, antibacterial, antihistamic, antipruritic and anti-inflammatory effects that can be used without damaging the human body and multiple tissue cells that completely eliminate viruses, bacteria and fungi and completely treat the diseases caused by them, and a disinfectant with PH level tissue compatible. a biocidal has not been found. Although drug treatments reduce the severity of viral infections, they cannot cure the disease completely; hence the disease may recur.

In addition, disinfectant products cannot completely destroy viruses and bacteria without damaging living cell tissue, multi-cell tissue in humans and animals.

Due to the increase in the number of pandemic cases and immunosuppressive patients in recent years, antiviral, antiseptic, antibacterial, antihistamic, antipruritic, anti-inflammatory therapy and biocidal agents have become very popular. Today, there are many agents with demonstrated activity. These agents have significantly improved the clinical progression of the diseases, but there are limitations in the treatment of chronic and occult infections. In this document, the mechanisms of action, clinical uses and important side effects of antiviral, antiseptic, antibacterial, antihistamic, antipruritic, anti-inflammatory drugs and biocidal agents are discussed.

Presently available drugs suppress the enzymes that control the DNA synthesis ability of viruses, bacteria, fungi and molds, the ability to self-replicate, and the factors that regulate their ribonucleotide synthesis metabolism. DNA polymerase, reverse transcriptase and ribonucleotide reductase can be cited as examples of such enzymes. Although this approach temporarily slows the progression of viral infections, viruses, bacteria, and fungi often become resistant to these components in the medium and long term. The general approach takes the form of fighting the symptoms of the infection, rather than fighting the underlying nature of the virus, bacteria, fungus-based infections itself.

In addition, currently available biocidal products for disinfectant purposes cannot kill all viruses, bacteria, fungi and molds with the same ability. As the killing effects increase, tissue compatibility in PH levels deteriorates at the same rate, causing dangerous burns, wounds and injuries, especially in the skin and respiratory tract.

As a result, the need for a compound for the treatment and disinfection of infections caused by viruses, bacteria, fungi and molds and the inadequacy of existing solutions, virus outbreaks affecting the whole world made it necessary to make an improvement in the relevant technique.

 

 

Files

0695a660-748c-447d-84ed-f9ec6d0b3c86 3.pdf

Files (759.2 kB)

Name Size Download all
md5:e502fefcc7a33c885c6a56537a3bc51c
76.7 kB Preview Download
md5:672a060fb15eea739320eea874f49f61
664.9 kB Download
md5:fdf49bc3c61affed1e20361fa8372414
17.6 kB Download